OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting
Adriaan Volkers, Mark Löwenberg, Marlou Braad, et al.
Diagnostics (2023) Vol. 13, Iss. 10, pp. 1712-1712
Open Access | Times Cited: 5
Adriaan Volkers, Mark Löwenberg, Marlou Braad, et al.
Diagnostics (2023) Vol. 13, Iss. 10, pp. 1712-1712
Open Access | Times Cited: 5
Showing 5 citing articles:
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Dahham Alsoud, Dirk Jan A. R. Moes, Zhigang Wang, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 3, pp. 291-308
Closed Access | Times Cited: 5
Dahham Alsoud, Dirk Jan A. R. Moes, Zhigang Wang, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 3, pp. 291-308
Closed Access | Times Cited: 5
Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry
Kevin P. Bliden, Parshotam Kundan, Danielle Kraft, et al.
Platelets (2024) Vol. 35, Iss. 1
Open Access
Kevin P. Bliden, Parshotam Kundan, Danielle Kraft, et al.
Platelets (2024) Vol. 35, Iss. 1
Open Access
Comparing Point-of-Care Technology to ELISA Testing for Infliximab and Adalimumab Levels in Adult Inflammatory Bowel Disease Patients: A Prospective Pilot Study
Erica Bonazzi, Daria Maniero, Greta Lorenzon, et al.
Diagnostics (2024) Vol. 14, Iss. 19, pp. 2140-2140
Open Access
Erica Bonazzi, Daria Maniero, Greta Lorenzon, et al.
Diagnostics (2024) Vol. 14, Iss. 19, pp. 2140-2140
Open Access
Infliximab Precision Dosing in Inflammatory Bowel Disease (IBD) Patients: A Review of Current Literature
Alexandros Toskas, Magdalini Manti, Nikolaos Kamperidis, et al.
Cureus (2024)
Open Access
Alexandros Toskas, Magdalini Manti, Nikolaos Kamperidis, et al.
Cureus (2024)
Open Access
Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels
Joel Thunberg, Olle Grännö, Daniel Bergemalm, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 150-155
Open Access | Times Cited: 1
Joel Thunberg, Olle Grännö, Daniel Bergemalm, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 150-155
Open Access | Times Cited: 1
